Gene therapy in urology: strategies to translate theory into practice.

about

Gene therapy in urology: strategies to translate theory into practice.

Item

http://www.wikidata.org/entity/Q36312228

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Gene therapy in urology: strategies to translate theory into practice.

@ast

Gene therapy in urology: strategies to translate theory into practice.

@en

type

Item

label

Gene therapy in urology: strategies to translate theory into practice.

@ast

Gene therapy in urology: strategies to translate theory into practice.

@en

prefLabel

Gene therapy in urology: strategies to translate theory into practice.

@ast

Gene therapy in urology: strategies to translate theory into practice.

@en

P1476

Gene therapy in urology: strategies to translate theory into practice.

@en

P2093

Chris H Bangma

http://www.w3.org/2001/XMLSchema#string

Ellen Schenk-Braat

http://www.w3.org/2001/XMLSchema#string

Pierre Mongiat

http://www.w3.org/2001/XMLSchema#string

Robert Kraaij

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors

Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoter

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.

Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.

Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display.

An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney.

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

Use of nude mouse xenograft models in prostate cancer research.

New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.

P304

1163-1170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2005.05929.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16285874

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy